as 03-25-2025 11:31am EST
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
Founded: | 2012 | Country: | United States |
Employees: | N/A | City: | IRVING |
Market Cap: | 136.0M | IPO Year: | N/A |
Target Price: | $8.00 | AVG Volume (30 days): | 307.7K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.09 | EPS Growth: | -30.22 |
52 Week Low/High: | $3.04 - $8.44 | Next Earning Date: | 03-12-2025 |
Revenue: | $197,191,000 | Revenue Growth: | 6.38% |
Revenue Growth (this year): | 17.51% | Revenue Growth (next year): | 15.84% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
HEYER ANDREW R | BTMD | Director | Mar 17 '25 | Buy | $3.95 | 75,000 | $296,042.50 | 370,201 | |
Cone Stephen Mark | BTMD | Director | Mar 17 '25 | Buy | $3.88 | 38,104 | $147,843.52 | 160,829 | |
Christensen Bret | BTMD | Chief Executive Officer | Mar 17 '25 | Buy | $3.87 | 37,595 | $145,492.65 | 37,595 | |
Guines LLC | BTMD | 10% Owner | Mar 13 '25 | Buy | $3.48 | 856,609 | $2,784,419.26 | 3,820,938 |
BTMD Breaking Stock News: Dive into BTMD Ticker-Specific Updates for Smart Investing
Argus Research
6 days ago
Simply Wall St.
6 days ago
Argus Research
7 days ago
Business Wire
8 days ago
Simply Wall St.
12 days ago
Thomson Reuters StreetEvents
13 days ago
GuruFocus.com
13 days ago
Zacks
14 days ago
The information presented on this page, "BTMD Biote Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.